Table 1.
Laboratory data
| Erythrocyte sedimentation rate | 2 | /l hr |
| Blood count | ||
| White blood cells | 3.70 | 3.30–9.00 mL |
| Red blood cells | 3.84 | 3.38–500 × 104/mL |
| Hemoglobin | 11.4 | 11.5–15.0 g/dL |
| Hematocrit | 34.2 | 34.8%–45.0% |
| Platelets | 10.1 | 14–34 × 104/μL |
| Blood coagulation | ||
| Prothrombin time and international normalized ratio | 1.93 | 0.85–1.15 |
| Hepaplastin test | 26 | 70%–130% |
| Antithrombin III | 36 | 81–12 |
| Urinalysis | ||
| Gravity | 1.021 | 1.006–1.0 |
| pH | 6 | 4.5–8.0 |
| Glucose | (−) | (−) mg/dL |
| Protein | (−) | (−) mg/dL |
| Blood | (−) | (−) |
| Ketone | (−) | (−) |
| Bilirubin | (−) | (−) |
| Urobilinogen | (−) | (−) |
| Blood chemistry | ||
| Total bilirubin | 6.6 | 0.2–1.2 mg/dL |
| Direct bilirubin | 4.4 | 0.0–0.2 mg/dL |
| Aspartate aminotransferase | 344 | 10–40 IU/L |
| Alanine aminotransferase | 238 | 5–45 IU/L |
| γ-glutamyl transpeptidase | 129 | 30 IU/dL |
| Alkaline phosphatase | 572 | 100–325 IU/l |
| Cholinesterase | 112 | 200–452 IU/I |
| Total protein | 7.3 | 6.7–8.3 g/dL |
| Albumin | 3.3 | 3.8–5.3 g/dL |
| Total cholesterol | 133 | 120–219 mg/dL |
| Blood urea nitrogen | 6.3 | 18.0–20.0 |
| Creatinine | 0.62 | 0.47–0.71 mg/dL |
| Fasting blood sugar | 143 | 70–109 mg/dL |
| Immunological and serological data | ||
| Hepatitis B surface antigen | (−) | |
| Hepatitis C surface antigen | (−) | |
| Hepatitis A antibody | (−) | <0.71 |
| IgM Hbc antibody | (−) | <1.0 |
| Hepatitis C virus RNA | <1.2 | <1.2 loglU/mL |
| CMV-IgM | 2.127 (+) | <0.8 |
| CMV-IgG | 10 (+) | <0.8 |
| EBV-VCA IgM | <10 | <×10 |
| EBV-VCA IgG | 1280 | <×10 |
| EBV-DNA PCR | (−) | |
| IgG | 2496 | 870–1700 mg/dL |
| IgM | 272 | 46–260 mg/dL |
| Fluorescent antinuclear antibody test | <×40 | <×40 |
| Antinuclear antibody (ELISA) | 44.1 (+) | <20 index |
| Anti-smooth muscle antibody | <×20 (−) | <×20 |
| Liver kidney microsomal type 1 antibody | <1.7 (−) | <5.0 |
| Anti-mitochondria M2 antibody | 18.4 (+) | <7.0 |
| Thyroid stimulating hormone | 1.254 | 0.436–3.8 μlU/mL |
| Free thyroxine | 1.14 | 1.0–1.7 ng/dL |
| Thyroglobulin | 0.7 (+) | <0.3 U/mL |
| Rheumatoid factor | 25 (+) | <20 |
| Rheumatoid arthritis hemagglutinin <×40 | 20 (−) | <40 |
| Cyclic citrullinated peptide | 8 (−) | <4.5 U/mL |
| Lupus anticoagulant: dilute | 1.1 (−) | <1.3 |
| Russell viper venom time | ||
| DNA | 5 (−) | <6 |
| Classicla antineutrophil cytoplasmic antibody | <3.5 (−) | <3.5 U/mL |
| Protoplasmic-straining antineutrophil cytoplasmic antibodies | <1.3 (−) | <9.0 U/mL |
| Total complement activity | 37.1 (−) | 29.0–48.0 U/mL |
| Anti-Jo-1 antibody | <1.0 (−) | <1.0 |
| Anti-ribonucleoprotein antibody | 20.3 (+) | <17.0 |
| Anti-SS-A antibody | <5.0 (−) | <15 |
| Anti-SS-B antibody | <5.0 (−) | <15.0 |
| Anti-centromere antibody | 6.5 (−) | <10.0 |
| Anti-Scl-70 antibody | <5.0 (−) | <16 |
| HLA-DR haplotypes | DR-4 |
Abbreviations: CMV, cytomegalovirus; DNA, deoxyribonucleic acid; EBV, Epstein-Barr virus; Ig Immunoglobulin; PCR, polymerase chain reaction; RNA, ribonucleic acid; VCA, virus capsid antigen.